Chemotherapy delay after primary debulking surgery for ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference21 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016
2. Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG oncology/gynecologic oncology group study;Tewari;Ann. Oncol.,2016
3. The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma—analysis of patient data in the prospective OVCAD study;Hofstetter;Gynecol. Oncol.,2013
4. Prognostic impact of the time interval between primary surgery and chemotherapy in patients with advanced ovarian cancer: analysis of prospective randomized phase III trials;Mahner;Eur. J. Cancer,2013
5. The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma;Rosa;Eur. J. Surg. Oncol.,2006
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The activity advantage: Objective measurement of preoperative activity is associated with postoperative recovery and outcomes in patients undergoing surgery with gynecologic oncologists;Gynecologic Oncology;2024-07
2. Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer;Indian Journal of Surgery;2024-06-10
3. An Audit on Factors Delaying Time to Chemotherapy in Stage IIB–IV Ovarian Cancer Patients After Primary Debulking Surgery;Indian Journal of Gynecologic Oncology;2024-05-07
4. Nutritional interventions during treatment for ovarian cancer: A narrative review and recommendations for future research;Maturitas;2024-05
5. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study;Gynecologic Oncology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3